Evidence map›Paper›PMID 39276205›Full record

ArticleArchives of dermatological research2024

Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia.

Divija Sharma, Benjamin Ungar, Jonas A Adalsteinsson, Jon Kristinn Sigurdsson, Kelley Sharp, Sigrún Thorsteinsdóttir, Saemundur Rögnvaldsson, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson and 14 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Divija SharmaDepartment of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA.
Benjamin UngarDepartment of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA.
Jonas A AdalsteinssonDepartment of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA. jonas.adalsteinsson@mountsinai.org.
Jon Kristinn SigurdssonUniversity of Iceland, Reykjavik, Iceland.
Kelley SharpFrank H. Netter MD School of Medicine, Quinnipiac University, North Haven, USA.
Sigrún ThorsteinsdóttirUniversity of Iceland, Reykjavik, Iceland.
Saemundur RögnvaldssonUniversity of Iceland, Reykjavik, Iceland.
Ásdís R ÞórðardóttirUniversity of Iceland, Reykjavik, Iceland.
Brynjar ViðarssonThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Páll T ÖnundarsonThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Bjarni A AgnarssondThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Margrét SigurðardóttirdThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Ingunn ÞorsteinsdóttirThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Ísleifur ÓlafssonThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Elías EyþórssonThe National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Ásbjörn JónssonAkureyri Hospital, Akureyri, Iceland.
Andri ÓlafssonUniversity of Iceland, Reykjavik, Iceland.
Gauti Kjartan GíslasonUniversity of Iceland, Reykjavik, Iceland.
Ola LandgrenMyeloma Program, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.
Malin HulcrantzMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brian Gm DurieCedars-Sinai Outpatient Cancer Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Stephen HardingBinding Site Group Ltd, Birmingham, UK.
Thorvardur Jon LoveUniversity of Iceland, Reykjavik, Iceland.
Sigurdur Yngvi KristinssonUniversity of Iceland, Reykjavik, Iceland.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlopeciaMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaSmoldering Multiple MyelomaAdultAgedCohort StudiesFemaleHumansMaleMass ScreeningMiddle AgedHair lossInflammatory hair lossMultiple myeloma (MM), smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), alopeciaNonscarring hair loss

Identifiers

PMID39276205
PMCPMC12509070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.